Pathologists' guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

Breast Care

Volumn 5, Issue 3, 2010, Pages 185-186

  Denkert, Carsten ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

BREAST CANCER; CLINICAL PRACTICE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MEDICAL SOCIETY; NOTE; ONCOLOGY; PATHOLOGIST; PHENOTYPE; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 77954477827     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000315039     Document Type: Note

References (9)

1. Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 2010: DOI 10.1200/JCO.2009.25.6529.
2. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF; American Society of Clinical Oncology; College of American Pathologists. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007;25:118-145. (Pubitemid 350003059)
3. Rudiger T, Hofler H, Kreipe HH, Nizze H, Pfeifer U, Stein H, Dallenbach E, Fischer HP, Mengel M, von Wasielewski R, Muller-Hermelink K: Interlaboratory trial 2000 'Immunohistochemistry' of the German Society for Pathology and the Professional Association of German Pathologists. Pathologe 2003;24:70-78.
4. von Wasielewski R, Mengel M, Wiese B, Rudiger T, Muller-Hermelink K, Kreipe H: Tissue array technology for testing interlaboratory and interobserver reproducibility of immunohistochemical estrogen receptor analysis in a large multicenter trial. Am J Clin Pathol 2002;118:675-682.
5. Mengel M, von Wasielewski R, Wiese B, Rudiger T, Muller-Hermelink K, Kreipe H: Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial. J Pathol 2002;198:292-299.
6. Rudiger T, Hofler H, Kreipe HH, Nizze H, Pfeifer U, Stein H, Dallenbach FE, Fischer HP, Mengel M, von Wasielewski R, Muller-Hermelink HK: Quality assurance in immunohistochemistry: results of an interlaboratory trial involving 172 pathologists. Am J Surg Pathol 2002;26:873-882.
7. Sotiriou C, Pusztai L: Advances in translational research in breast cancer; a bridge to future therapies. Eur J Cancer 2008;44:2705-2706.
8. Sotiriou C, Pusztai L: Gene-expression signatures in breast cancer. N Engl J Med 2009;360:790-800.
9. Faratian D, Kay C, Robson T, Campbell FM, Grant M, Rea D, Bartlett JM: Automated image analysis for high-throughput quantitative detection of ER and PR expression levels in large-scale clinical studies: the TEAM Trial Experience. Histopathology 2009;55:587-593.